ヒトがんゲノムにおける再発性再発拡大
Graham S Erwin1, Gamze Gürsoy2,3, Rashid Al-Abri4
1Department of Genetics, Stanford University, Stanford, CA, USA. gerwin@stanford.edu.
Nature
|December 14, 2022
まとめ
病気を引き起こすことが知られている DNAの繰り返し拡張は,様々な癌の重要な要因として新たに特定されています. 研究者らは 癌のサブタイプと潜在的な遺伝子調節に関連した 特定の再発拡大を発見し 癌の研究に新たな道を開きました
科学分野:
- ゲノミクス
- 癌 生物学
- 分子遺伝学
背景:
- タンデムリピート (TR) 拡張は50以上の病気を引き起こすが,がんにおけるその役割は十分に研究されていない.
- 短いTRの微小衛星の不安定性は癌で知られているが,より大きなTRの拡張はほとんど調査されていない.
- 既存の研究は主に神経疾患に焦点を当てており,がんなどの他の疾患におけるTR拡大を無視しています.
研究 の 目的:
- 多種多様な癌のタンデム・リピート・エクスパンションを 体系的に特定し分析する.
- がんにおける再発性再発拡大 (rRE) のゲノム分布と潜在的な規制的役割の調査.
- 癌細胞の特定の再発拡大を標的とした治療の可能性を調査する.
主な方法:
- 29種類の異なるがんの2,622のがんゲノムを分析してTR拡大を特定した.
- 再発的な再発拡大 (rREs) を検出し,そのゲノム分布を評価するためのバイオ情報分析.
- UGT2B7近くのGAAA-リピート拡張を含む特定のrREの検証のためのロングリードDNAシーケンシング.
- 癌細胞増殖に対する特定のrREを標的とする効果を評価するための予備的なin vitro実験.
主要な成果:
- 29種類のがんの2,622のガンゲノムに TR拡張が確認された.
- 7つのがんタイプで160件の再発性再発拡大 (rREs) が発見され,そのほとんどはサブタイプ特異的であった.
- 発見されたrREは,候補 cis 調節要素の近くで濃縮され,遺伝子調節における役割を示唆しています.
- 34%の腎臓細胞がんのサンプルでUGT2B7の近くのGAAA-リピート拡大が検出され,シーケンシングで検証されました.
- 予備実験では,GAAA標的分子による治療で,がん細胞増殖の量に依存する減少が観察されました.
結論:
- 繰り返しの再発はヒトの癌における 遺伝子変異の重要かつ未知の源である.
- この発見は,rREががん発症を誘発する可能性を強調し,がんバイオマーカーとしての有用性を示唆しています.
- rREsの包括的なカタログが提供され,その機能的役割と腫瘍学における治療標的に関するさらなる研究への道を開く.
さらに関連する動画
09:13Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells
Published on: January 17, 2019
7.4K
03:55Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
1.4K
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Non-LTR Retrotransposons
11.7K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.7K
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Cancer
49.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.1K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
